Potassium

Potassium

SCHEMBL408268

NNC(=O)C=CC(=O)O.[K]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.50
EGLN1 Q9GZT9 1/20 0.50
EGLN3 Q9H6Z9 1/20 0.50
ALDH1A1 P00352 6/20 0.46
GAA P10253 3/20 0.46
POLB P06746 1/20 0.44
LPAR2 Q9HBW0 3/20 0.40
LPAR3 Q9UBY5 2/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 3/20 0.39
LPAR1 Q92633 1/20 0.39
TDP2 O95551 1/20 0.39
THRB P10828 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 3/20 0.38
NMT1 P30419 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557416 0.97
SCHEMBL55072 0.97
SCHEMBL27799720 0.97
Hydrochloric Acid SCHEMBL20529478 0.94 TSHR (0.50) TSHRTP53EGLN1EGLN3ALDH1A1
SCHEMBL8367461 0.94 TSHR (0.50) TSHRTP53EGLN1EGLN3ALDH1A1
SCHEMBL9489254 0.94 TSHR (0.50) TSHRTP53EGLN1EGLN3ALDH1A1
Ammonia Solution, Strong SCHEMBL7116627 0.94 TSHR (0.50) TSHRTP53EGLN1EGLN3ALDH1A1
Ethylene SCHEMBL27598143 0.92 TSHR (0.47) TSHRTP53EGLN1EGLN3ALDH1A1
Water SCHEMBL28280740 0.92 TSHR (0.47) TSHRTP53EGLN1EGLN3ALDH1A1
Acetic Acid SCHEMBL5904005 0.90 ALDH1A1 (0.48) TSHRTP53EGLN1EGLN3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113712035-B Solid bud inhibitor and preparation method thereof 江苏中烟工业有限责任公司 2023-01-31 CN claimed
US-8337900-B2 Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulation WDG-CS, ZC, EC-SC, and CX FMC CORPORATION 2012-12-25 US claimed
US-20090053271-A1 Reverse-Phase Microcapsules for Actice Ingredients, Simplified Process of Manufacture Thereof and Combined Formulation Wdg- Cs,Zc, Ec-Sc, and Cx FMC CORPORATION 2009-02-26 US claimed
EP-2004718-A1 REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX GAT Microencapsulation AG (AT) 2008-12-24 EP claimed
WO-2007112933-A1 REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX GAT MICROENCAPSULATION AG (AT) 2007-10-11 WO claimed
WO-2025078992-A1 METHOD OF CONTROLLING WEEDS UPL MAURITIUS LIMITED (MU) 2025-04-17 WO disclosed
CN-114008045-B Agricultural and horticultural agent containing novel imidazopyridine-2-carboxamide derivative as active ingredient 阿格罗-金正株式会社 2024-07-16 CN disclosed
US-20240188560-A1 STABLE EMULSIONS ADAMA AGAN LTD. (IL) 2024-06-13 US disclosed
WO-2024117205-A1 BICYCLIC PYRIDINE DERIVATIVE AND SALT THEREOF, AND HARMFUL ORGANISM CONTROL AGENT CHARACTERIZED BY CONTAINING SAID DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT 北興化学工業株式会社 2024-06-06 WO disclosed
US-20230240287-A1 AGROCHEMICAL COMPOSITION BATTELLE UK LIMITED (GB) 2023-08-03 US disclosed
EP-4169379-A2 AGROCHEMICAL COMPOSITION Battelle UK Limited (GB) 2023-04-26 EP disclosed
CN-113712035-B Solid bud inhibitor and preparation method thereof 江苏中烟工业有限责任公司 2023-01-31 CN disclosed
US-20090069386-A1 Liquid Composition, Process for Producing the Liquid Composition,and Ectoparasite Controlling Agent for Use in Mammals and Avians NIPPON SODA CO., LTD. (JP) 2009-03-12 US disclosed
US-20090053271-A1 Reverse-Phase Microcapsules for Actice Ingredients, Simplified Process of Manufacture Thereof and Combined Formulation Wdg- Cs,Zc, Ec-Sc, and Cx FMC CORPORATION 2009-02-26 US disclosed
EP-2014163-A1 LIQUID COMPOSITION, PROCESS FOR PRODUCTION OF THE LIQUID COMPOSITION, AND ECTOPARASITE CONTROLLING AGENT FOR USE IN MAMMALS AND AVIANS Nippon Soda Co., Ltd. (JP) 2009-01-14 EP disclosed
EP-2004718-A1 REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX GAT Microencapsulation AG (AT) 2008-12-24 EP disclosed
WO-2007112933-A1 REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX GAT MICROENCAPSULATION AG (AT) 2007-10-11 WO disclosed
EP-0134339-B1 HERBICIDAL COMPOSITION JAPAN HYDRAZINE CO., LTD. (JP) 1987-10-21 EP disclosed
EP-0134339-A1 Herbicidal composition JAPAN HYDRAZINE CO., LTD. (JP) 1985-03-20 EP disclosed
US-4404016-A ISOPROPYL N-(3-CHLOROPHENYL) CARBAMATE IN ALKYLENE GLYCOL PPG INDUSTRIES, INC. (US) 1983-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240287-A1 AGROCHEMICAL COMPOSITION UGCG, PHOSPHO1, SGMS2 TSHR 3959/4885TP53 1903/4885EGLN1 897/4885
US-20240188560-A1 STABLE EMULSIONS POLR2H, POLR2E, PHOSPHO1 TSHR 1862/4885TP53 450/4885EGLN1 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.